Introduction
Generally, gastric carcinomas are classified into two histological types by standard hematoxylin and eosin (H&E) staining; such as "intestinal" type and "diffuse" type, by Lauren [1] , and "differentiated" type and "undifferentiated" type by Nakamura et al. [2] . It has been considered that intestinal-type carcinoma is similar to differentiated-type carcinoma and that diffuse-type carcinoma and undifferentiated-type carcinoma are similar and show a gastric phenotype. However, there are currently various opinions regarding the classification of gastric carcinoma phenotypes by mucin-histochemical or immunohistochemical methods. The existence of differentiated-type gastric carcinomas having a gastric phenotype has been proved. Tatematsu et al. [3] and Egashira [4] reported that about 30% of differentiatedtype gastric carcinomas showed a gastric phenotype, by immunohistochemical or mucin-histochemical studies. We have reported that, in immunohistochemical studies, 38.8% of differentiated-type gastric carcinomas showed a gastric phenotype [5] . Generally, differentiated-type gastric carcinomas with a gastric phenotype are considered to have high invasiveness and high metastatic potential compared with differentiated-type gastric carcinomas with an intestinal phenotype [6] [7] [8] [9] [10] [11] . It has been reported that there are undifferentiatedtype gastric carcinomas having an intestinal phenotype [12, 13] . Fiocca et al. [14] and Yamachika et al. [15] classified the phenotypes of gastric signet-ring cell carcinomas, and reported that the progression of gastric carcinomas was associated with a phenotypic shift from gastric type to intestinal type. Similarly, Yao et al. [16] reported that intestinalization frequently occurred during neoplastic transformation. It can be conjectured that there are biological differences between undifferentiated-type gastric carcinomas with a gastric phenotype and those with an intestinal phenotype. But there has been no report about comparisons of biological behav-ior between undifferentiated-type gastric carcinomas having a gastric phenotype and those having an intestinal phenotype.
In the study, we report here, we classified the phenotypes of early undifferentiated-type gastric carcinomas according to the type of intestinal metaplasia [5] and investigated the relationship between their biological behavior and the phenotypes.
Materials and methods

Materials
From our pathological files of gastric specimens that had been surgically resected at Kyushu University Hospital and its affiliated hospitals, 60 lesions of intramucosal undifferentiated-type gastric carcinoma were randomly selected for the present study. Undifferentiated-type gastric carcinoma was defined as poorly differentiated adenocarcinoma or signet-ring cell carcinoma. All the lesions were cut into serial step sections of 3-4 mm in width, fixed in 10 % formalin solution, and embedded in paraffin. Macroscopic and histological evaluations were made according to the classification established by the Japanese Research Society for Gastric Cancer [17] . The macroscopic features were divided into three major types; type I (polypoid), type II (superficial), and type III (excavated). Type II was further divided into three subtypes: type IIa (elevated), type IIb (flat), and type IIc (depressed). Composite types were classified based on the predominant subtype; for example, type IIc+III was considered to be type IIc. The depth of invasion and histological grade were classified according to the predominant component.
Immunohistochemical staining
To classify the phenotypic expression, the expressions of CD10, MUC2, small intestinal mucinous antigen (SIMA), human gastric mucin (HGM), or concanavalin A (ConA) were investigated by immunohistochemical methods. We consider that CD10, MUC2, and SIMA are detected in the intestinal phenotype, while HGM and ConA are detected in the gastric phenotype. The staining of CD10, MUC2, HGM, and ConA was carried out according to previous studies [5] . The staining of SIMA was carried out by the streptavidin-biotin (SAB) method with an antibody against SIMA (SIMA-4D3; NovoCastra, Newcastle, England) and SAB-PO (mouse) kits (Nichirei, Tokyo, Japan). Sections (4-mmthick) were deparaffinized in xylene, hydrated through a graded series of ethanol, and immersed in 3% hydrogen peroxide, followed by immersion in 100% methanol for 30 min to inhibit endogenous peroxidase. To activate the antigens, the slides were placed in a microwave oven in 10 mM citrate buffer (pH 6.0) for 30 min. After a rinsing in phosphate-buffered saline (PBS), the slides were incubated in humid chambers with the primary antibodies, SIMA at 1 : 100, overnight at 4°C, followed by three washes with PBS. The sections were then incubated with biotinylated anti-mouse immunoglobulin (Ig) G, IgA, and IgM for 20 min, and with peroxidaseconjugated streptavidin for 20 min. After being washed in PBS, the slides were developed by being immersed in 0.01% H2O2 and 0.05% diaminobenzidine tetrahydrochloride (DAB) for 3 min. A light counterstaining with Mayer's hematoxylin was carried out. The results of staining were categorized into two groups: positive expression and negative expression. When more than 10% of the carcinoma cells in the neoplastic areas were stained, it was classified as positive expression. When fewer than 10% of the carcinoma cells in the neoplastic areas were stained, it was classified as negative expression.
Classification and comparisons of phenotypic expression
Classification of the phenotypes of the carcinomas and the background mucosas was based on the classification of intestinal metaplasia (complete-type intestinal metaplasia, incomplete-type intestinal metaplasia, or nonmetaplastic gastric mucosa) by immunohistochemical staining, according to previous studies [5, 18] . The phenotypes were classified into four groups; gastric type, incomplete-intestinal type, complete-intestinal type, and unclassified type, according to the combination of the expression of CD10, MUC2, SIMA, HGM, or ConA. Figure 1 summarizes the classification of the Fig. 1 . Classification of phenotypes. The phenotypes were classified into four groups; gastric type, incomplete-intestinal type, complete-intestinal type, and unclassified type, according to the combination of the expression of CD10, MUC2, small-intestinal mucinous antigen (SIMA), human gastric mucin (HGM), or concanavalin A (ConA) and ConA, while the laminar surface of the carcinoma was positive for CD10. The incidence of gastric-type carcinomas, incomplete intestinal-type carcinomas, and complete intestinal-type carcinomas was 33% (20 cases), 65% (39 cases), and 2% (1 cases), respectively. Table 1 shows the clinicopathological findings of the 20 gastric-type carcinomas and 40 intestinal-type carcinomas (incomplete-intestinal-type carcinomas and complete-intestinal-type carcinomas). Intestinal-type carcinomas tended to be larger than gastric-type carcinomas, but there were no significant differences in any clinicopathological factors examined between gastrictype carcinomas and intestinal-type carcinomas. Table 2 shows the morphological findings of the 20 gastric-type carcinomas and the 40 intestinal-type carcinomas. Intestinal-type carcinomas had a glandular structure more frequently than gastric-type carcinomas. Gastric-type carcinomas had the middle-layer type spreading pattern more frequently than intestinal-type carcinomas. On the other hand, intestinal-type carcinomas had the whole-layer type spreading pattern more frequently than gastric-type carcinomas. In addition, the whole-layer-type carcinomas tended to be larger than the middle-layer-type carcinomas (average size, 3.3 cm vs 2.8 cm). Table 3 shows the relationship between the phenotype of the carcinomas and that of the background mucosa. The phenotype of the carcinomas was significantly related to that of their own background mucosa (P = 0.0440). The spreading pattern of gastric-type carcino- Fig. 2 . Spreading features. The spreading features were classified into two patterns, the middle-layer type and the whole-layer type. In the middle-layer type, the carcinoma cells mainly spread in the gastric mucosa between the proper foveolae. In the whole-layer type, the carcinoma cells mainly expand in the gastric mucosa with destruction of the foveolae phenotypes of the carcinomas and the background mucosas. We compared the clinicopathological findings and the morphological findings (including the existence of glandular structures or signet-ring cells and the spreading pattern) between gastric-type carcinomas and intestinal-type carcinomas (including incompleteintestinal-type carcinomas and complete-intestinal-type carcinomas). The spreading patterns were classified into two types, middle-layer type and whole-layer type, as shown in Fig. 2 .
Morphological findings
Relationship between carcinoma phenotype and that of the background mucosa
Statistical analyses
The BMDP statistical package program (BMDP; Los Angeles, CA, USA) for an IBM (Armonk, NY, USA) 4381 mainframe computer was used for all analyses. The relationships between the clinicopathological findings or the morphological findings and the phenotypes were examined by the c 2 test and Kruskal-Wallis test. The level of significance was less than 0.05.
Results
Clinicopathological findings
Gastric-type carcinoma is shown in Fig. 3 . This carcinoma showed the middle-layer-type spreading pattern. The upper layer of the carcinoma was positive for HGM, while the lower layer of the carcinoma was positive for ConA, as was the normal layer structure of gastric proper mucosa. Incomplete-intestinal-type carcinoma is shown in Fig. 4 . This carcinoma showed the whole-layer-type spreading pattern. This carcinoma was negative for HGM and ConA, and positive for SIMA. Complete-intestinal-type carcinoma is shown in Fig. 5 . This carcinoma had structures of small trabeculae and microglands. This carcinoma was negative for HGM mas tended to be the middle-layer type and the spreading pattern of intestinal-type carcinomas tended to be the whole-layer type, regardless of the phenotype of their own background mucosa.
Discussion
In this study, we classified the phenotypes of undifferentiated-type gastric carcinomas, based on the expression of CD10, MUC2, SIMA, HGM, or ConA and the classification of intestinal metaplasia. In previous studies, it was shown that CD10, MUC2, HGM, and ConA were expressed in the brush border, the goblet cells, the gastric foveolar epithelium, and the pyloric glands, individually [19] [20] [21] [22] [23] [24] [25] [26] . We employed SIMA, for the first time, for the evaluation of intestinal phenotypic expression. SIMA is a 1000-kDa mucin glycoprotein antigen that is known to be present in the goblet cells and the extracellular mucin of the small intestine. SIMA is not present in normal stomach and normal adult large bowel. But SIMA is reported to be present in cancers of the stomach and large bowel [27] [28] [29] [30] . In this study, 67% of undifferentiated-type gastric carcinomas had an intestinal phenotype. Sepulveda et al. [31] reported that 46% of undifferentiated-type gastric carcinomas had an intestinal phenotype. Fujimori et al. [32] reported diffuse-type gastric carcinomas that were composed of Paneth-cell-type carcinoma cells. Wang et al. [33] reported diffuse-type gastric carcinomas that expressed human colonic mucin (HCM14 or HCM21).
In differentiated-type gastric carcinomas, it was reported that intramucosal carcinomas tended to have a phenotype similar to the phenotype of the background mucosa. It has also been demonstrated that even intramucosal diffuse-type gastric carcinomas have the laminated structure of mucins similar to that in the background mucosa [34] [35] . In the present study, several carcinomas were positive for the foveolar epithelial marker (HGM) in the upper layer and positive for the pyloric glandular marker (ConA) in the lower layer, similar to the layer structure of the gastric proper mucosa. Also, the phenotype of the carcinomas tended to imitate the phenotype of their own background mucosa, as reported in previous studies. It is considered that intramucosal carcinomas, even those of the undifferentiated type, tend to keep the phenotype of the background mucosa. Solcia et al. [36] reported that there were two carcinogenetic pathways of diffuse-type gastric carcinoma. We also consider that undifferentiatedtype gastric carcinomas have a carcinogenetic pathway not only from the gastric proper mucosa but also a carcinogenetic pathway from intestinal metaplasia. We considered that, as gastric carcinomas increased in size, the whole-layer type was shown, and that the progression of carcinomas was associated with a phenotypic shift from gastric-type expression to intestinal-type expression, as Yamachika et al. [15] and Yao et al. [16] have reported.
In this study, there were no clinicopathological differences between gastric-type carcinomas and intestinaltype carcinomas, but there were morphological differences. Gastric-type carcinomas more commonly had the middle-layer type, spreading pattern compared with intestinal-type carcinomas. In a carcinoma with the middle-layer type, spreading pattern the tumor margins tend to be unclear, because the carcinoma cells do not appear at the surface of the mucosa. So the margin of gastric-type carcinoma is considered to be unclear. Similarly, in differentiated-type carcinomas, Yoshino et al. [6] reported that the margin of gastric-type carcinoma was unclear compared with that in intestinal-type carcinoma. For gastric-type carcinomas, in particular the area to be resected and the choice of endoscopic mucosal resection (EMR) has to be carefully considered.
Our immunohistochemical method can be used to classify the phenotypes of gastric carcinomas, without regard to the presence or absence of a glandular structure, and we have shown that undifferentiated-type carcinomas frequently express an intestinal phenotype. There were differences in the growth patterns between undifferentiated-type gastric carcinomas with a gastric phenotype and those with the intestinal phenotype.
